FOUNTAIN HILLS, Ariz., June 28 /PRNewswire-FirstCall/ -- Sunridge International (OTC Bulletin Board: SNDZ), announced today that it has completed production and delivery of 60 PNT Units and 10,000 disposable rings to its exclusive distributor, Beijing Vision World Trading Company (BV) of China.
This order marks the marketing rollout of PNT in China, and the first order since recently receiving approval for PNT by the State Food and Drug Administration of China. Marketing and training for Sunridge's patented glaucoma treatment is moving forward at a good pace states a spokesperson for BV. These units and rings will be delivered to hospitals, doctors, and private clinics. 10 units will also be delivered per a signed agreement with the China Disabled Persons Federation, and the hospitals affiliated with them. BV is holding seminars throughout China to provide PNT training in the various provinces. They are also producing a TV program on glaucoma and PNT, and expect it to air next month.
"I am very happy about how well BV is moving forward with their marketing program," states G. Richard Smith, CEO of Sunridge. "They are very professional and are doing exceptionally well with a market as large as China. BV has indicated that they expect to place their next order for additional units and rings in September."
Glaucoma is the second leading cause of blindness, affecting over 70 million people worldwide. PNT has been proven (through studies completed over the last 10 yrs) to be a safe, effective, non-invasive and a cost effective alternative for treatment for glaucoma and ocular hypertension. The 2-minute treatment has been developed, patented, and distributed by Sunridge International, wholly owned subsidiary, Ophthalmic International (www.oi-pnt.com).
SOURCE Sunridge International